Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-21.65%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-21.65%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
3.6
1.09%
60%
—
-100.00%
Never
—
5 Years
Score3.6
Net Growth1.09%
Net Trend60%
Net Income Consistency—
Rev Growth-100.00%
Rev TrendNever
Revenue Consistency—
Phio Pharmaceuticals Corp fundamental performance
Between 2020 and 2025, revenue declined from $ 4.36K to $ 0.00 and net income went from -$ 8M to -$ 8M. Revenue increased in 0 of those 5 years; net income in 3.
Across Phio Pharmaceuticals Corp's full reported history, from 2012 to 2025, revenue declined from $ 97K to $ 0.00 and net income went from -$ 12M to -$ 8M. Revenue increased in 15% of the years measured; net income in 54%.
Phio Pharmaceuticals Corp currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.08 | — |
1 Year2025-08-12 | $ 2.14 | -49.53% |
5 Years2021-08-12 | $ 189.00 | -99.43% |
10 Years2016-08-12 | $ 139K | -100.00% |
All Time2012-05-10 | $ 1000K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2012-05-10 |
|---|---|---|---|---|---|
| Price | $ 1.08 | $ 2.14 | $ 189.00 | $ 139K | $ 1000K |
| Return | — | -49.53% | -99.43% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 8M | $ 21M |
| 2024 | $ 0.00 | -$ 7M | $ 5M |
| 2023 | $ 0.00 | -$ 10M | $ 8M |
| 2022 | $ 0.00 | -$ 11M | $ 11M |
| 2021 | $ 0.00 | -$ 13M | $ 24M |
| 2020 | $ 4.36K | -$ 8M | $ 14M |
| 2019 | $ 21K | -$ 8M | $ 6M |
| 2018 | $ 138K | -$ 7M | $ 14M |
| 2017 | $ 15K | -$ 12M | $ 3M |
| 2016 | $ 19K | -$ 8M | $ 12M |
| 2015 | $ 34K | -$ 10M | $ 10M |
| 2014 | $ 71K | -$ 8M | $ 8M |
| 2013 | $ 399K | -$ 20M | $ 14M |
| IPO2012 | $ 97K | -$ 12M | $ 5M |
Explore beyond PHIO
You're looking at Phio Pharmaceuticals Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
